202 related articles for article (PubMed ID: 26122842)
21. New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study.
Schraibman V; Goldman SM; Ardengh JC; Goldenberg A; Lobo E; Linhares MM; Gonzales AM; Abdala N; Abud TG; Ajzen SA; Jackowsky A; Szejnfeld J
Pancreatology; 2011; 11(1):43-51. PubMed ID: 21412024
[TBL] [Abstract][Full Text] [Related]
22. Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.
Cao Z; Maupin K; Curnutte B; Fallon B; Feasley CL; Brouhard E; Kwon R; West CM; Cunningham J; Brand R; Castelli P; Crippa S; Feng Z; Allen P; Simeone DM; Haab BB
Mol Cell Proteomics; 2013 Oct; 12(10):2724-34. PubMed ID: 23836919
[TBL] [Abstract][Full Text] [Related]
23. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
[TBL] [Abstract][Full Text] [Related]
24. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.
Yu KH; Barry CG; Austin D; Busch CM; Sangar V; Rustgi AK; Blair IA
J Proteome Res; 2009 Mar; 8(3):1565-76. PubMed ID: 19199705
[TBL] [Abstract][Full Text] [Related]
25. The role of cytopathology and cyst fluid analysis in the preoperative diagnosis and management of pancreatic cysts >3 cm.
Chebib I; Yaeger K; Mino-Kenudson M; Pitman MB
Cancer Cytopathol; 2014 Nov; 122(11):804-9. PubMed ID: 25044974
[TBL] [Abstract][Full Text] [Related]
26. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
27. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts.
Sainani NI; Saokar A; Deshpande V; Fernández-del Castillo C; Hahn P; Sahani DV
AJR Am J Roentgenol; 2009 Sep; 193(3):722-31. PubMed ID: 19696285
[TBL] [Abstract][Full Text] [Related]
28. Mass Spectrometry-Based Comprehensive Analysis of Pancreatic Cyst Fluids.
Paziewska A; Polkowski M; Rubel T; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Dadlez M; Ostrowski J
Biomed Res Int; 2018; 2018():7169595. PubMed ID: 30627566
[TBL] [Abstract][Full Text] [Related]
29. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a new approach to the preoperative assessment of pancreatic cystic lesions.
Lewandrowski K; Lee J; Southern J; Centeno B; Warshaw A
AJR Am J Roentgenol; 1995 Apr; 164(4):815-9. PubMed ID: 7537015
[TBL] [Abstract][Full Text] [Related]
30. Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos).
Fusaroli P; Serrani M; De Giorgio R; D'Ercole MC; Ceroni L; Lisotti A; Caletti G
Pancreas; 2016 Feb; 45(2):265-8. PubMed ID: 26474428
[TBL] [Abstract][Full Text] [Related]
31. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
32. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
[TBL] [Abstract][Full Text] [Related]
33. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.
Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR
Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880
[TBL] [Abstract][Full Text] [Related]
34. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
[TBL] [Abstract][Full Text] [Related]
36. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
[TBL] [Abstract][Full Text] [Related]
37. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
38. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
39. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
[TBL] [Abstract][Full Text] [Related]
40. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis.
Takenami T; Maeda S; Karasawa H; Suzuki T; Furukawa T; Morikawa T; Takadate T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Unno M
BMC Cancer; 2019 Apr; 19(1):318. PubMed ID: 30953499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
